GMAB Genmab A/S ADS Forecast, Technical & Fundamental Analysis

an international biotechnology company, which develops human antibody therapeutics for the treatment of cancer and other diseases.

Industry Biotechnology

Get AI intraday signals

GMAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GMAB
(Try 14 days for Free)

View a ticker or compare two or three

Compare

GMAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GMAB
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

GMAB is expected to report earnings to rise 24.20% to 35 cents per share on February 12

Genmab A/S ADS GMAB Stock Earnings Reports

Q4'24

Est.

$0.36

Q3'24

Missed

by $0.02

Q2'24

Beat

by $0.01

Q1'24

Est.

$0.29

Q4'23

Missed

by $0.17

The last earnings report on November 06 showed earnings per share of 28 cents, missing the estimate of 30 cents. With 707.54K shares outstanding, the current market capitalization sits at 12.92B.

A.I. Advisor

published General Information

General Information

an international biotechnology company, which develops human antibody therapeutics for the treatment of cancer and other diseases.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Carl Jacobsens Vej 30

Phone

+45 70202728

Employees

2204

Web

https://www.genmab.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	31.26	1.82	+6.18%
GameStop Corp
TSLA	479.86	16.84	+3.64%
Tesla
AAPL	253.48	2.44	+0.97%
Apple
BTC.X	106140.600000	110.890625	+0.10%
Bitcoin cryptocurrency
SPY	604.29	-2.50	-0.41%
SPDR® S&P 500® ETF Trust

GMAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GMAB has been loosely correlated with VIR. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if GMAB jumps, then VIR could also see price increases.

Ticker / NAME	Correlation To GMAB	1D Price Change %
GMAB	100%	+0.05%
VIR - GMAB	39% Loosely correlated	-2.78%
PGEN - GMAB	39% Loosely correlated	+2.46%
CRSP - GMAB	38% Loosely correlated	+0.88%
BCAB - GMAB	37% Loosely correlated	-2.96%
RCKT - GMAB	36% Loosely correlated	+1.36%
More